Improved targeting and enhanced retention of the human, autologous, fibroblast-derived, induced, pluripotent stem cells to the sarcomeres of the infarcted myocardium with the aid of the bioengineered, heterospecific, tetravalent antibodies.
about
'Above all, do no harm': safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis.Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration.Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of DNASE1, DNASE1L3, DNASE2, DFFB Controlled By POLA1 Promoter in Proliferating and Directed Differentiation Resisting Human Autologous PluripDirected cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies.Pluripotent Stem Cell Therapy in Ischemic Cardiovascular Disease.Suicide Gene Therapy for Cancer - Current Strategies.Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.
P2860
Q33826992-0DEDC72A-BC9D-4214-9CC5-4C4701646C67Q33909634-3B269CEA-759D-4D82-93C3-D4D829FDCB94Q33920686-03B5400B-0D7D-4788-B5B3-FD2F9352E4FCQ34039059-40078736-7CB7-4C17-96E6-FB11CB36D2BFQ36807721-8284C5DB-6423-4ED5-BB77-0757E9A8DA95Q37347017-80DE0846-1834-45BA-994C-4251D961192FQ42359748-671D50B8-8AE6-4630-B5DE-4F7297472C8B
P2860
Improved targeting and enhanced retention of the human, autologous, fibroblast-derived, induced, pluripotent stem cells to the sarcomeres of the infarcted myocardium with the aid of the bioengineered, heterospecific, tetravalent antibodies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improved targeting and enhance ...... cific, tetravalent antibodies.
@en
Improved targeting and enhance ...... cific, tetravalent antibodies.
@nl
type
label
Improved targeting and enhance ...... cific, tetravalent antibodies.
@en
Improved targeting and enhance ...... cific, tetravalent antibodies.
@nl
prefLabel
Improved targeting and enhance ...... cific, tetravalent antibodies.
@en
Improved targeting and enhance ...... cific, tetravalent antibodies.
@nl
P2860
P1476
Improved targeting and enhance ...... ecific, tetravalent antibodies
@en
P2093
Marek Malecki
P2860
P356
10.4172/2157-7633.1000138
P577
2013-05-01T00:00:00Z